Management In End Stage Renal Disease Pa... | Anemia

Anemia management in End-Stage Renal Disease (ESRD) focuses on stimulating red blood cell production while maintaining safe iron levels to minimize the need for blood transfusions . Because the kidneys can no longer produce enough erythropoietin (EPO), treatment involves replacing this hormone or stabilizing natural pathways. 1. Erythropoiesis-Stimulating Agents (ESAs)

) due to increased risks of stroke and cardiovascular events. Include Epogen , Procrit, and Aranesp. 2. Iron Supplementation Anemia management in End Stage Renal Disease pa...

ESAs are the standard injectable therapy that mimics the hormone EPO to signal bone marrow to produce more red blood cells. Generally maintained between Safety Warning: Clinicians avoid "normalizing" Hb (above Anemia management in End-Stage Renal Disease (ESRD) focuses